Work

Abstract 1784: Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations

Year: 2010

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am10-1784

Authors: Wee-Lee Yeo, Gregory J. Riely, Mark G. Kris, Daniel G. Tenen, William Pao, Susumu Kobayashi, Daniel B. Costa

Institutions: Beth Israel Deaconess Medical Center, Harvard University, National University of Singapore, Memorial Sloan Kettering Cancer Center, Vanderbilt-Ingram Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2557772662

Cites:

Cited by:

Related to: 10